Beta Bionics, Inc. BBNX

21.51 (0.25) (1.15%) as of 25 Sep
Market cap
$1.2B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23
Cash and Short Term Investments
219.23 103.58 96.75
Receivables
17.12 12.00 4.45
Inventory
21.72 13.32 1.25
Total current assets
267.91 132.92 103.62
Property, Plant, Equpment (Net)
8.60 4.78 2.48
Long-Term Investments
45.43 — —
Long-term assets (Other)
0.18 0.25 0.22
Total non-current assets
60.84 16.72 6.42
Total Assets
328.74 149.65 110.04
Accounts Payable
5.00 2.85 1.17
Accrued Expenses
22.43 15.83 8.13
Current Revenue (Deferred)
1.56 0.94 0.09
Total current liabilities
30.92 21.15 10.61
Non-current Revenue (Deferred)
3.30 1.86 0.26
Liabilities (Preferred Stock)
— 321.37 261.71
Non-current Liabilities (Other)
1.55 44.90 37.57
Total non-current liabilities
10.21 373.86 302.54
Total liabilities
41.13 395.01 313.15
Additional Paid In Capital
657.14 51.31 26.42
Common Stock (Net)
0.00 0.00 0.00
Retained Earnings
(369.94) (296.74) (229.66)
Common Equity (Total)
287.61 (245.36) (203.10)
Shareholders Equity (Total)
287.61 (245.36) (203.10)
Shareholders Equity and Liabilities (Total)
328.74 149.65 110.04
Shares (Common)
44.36 6.67 6.02
Shareholders Equity (Tangible)
287.61 (245.36) (203.10)
Net Debt
(219.22) (103.57) (96.74)

Fold the line items

In millions of $ except per-share values · columns are period end dates